FT-026

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameFT-026
Drug Alias Nameantifibrotic agents (Shire)antifibrotic agents (Fibrotech Therapeutics)FT-028FT-023FT-026
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsFibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New ZealandIreland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFibrotech Therapeutics Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsFibrosis

Other Information

ATC CodeN/A
Related LinksN/A